SCI's 7th Annual Capital Relief Trades Seminar

13 October 2021, London (In-Person Event)

London

One Bishops Square, London
E1 6AD

13 October 2021

25+ Speakers

Leading figures in the Risk Transfer & Synthetics Sector

250 Seats

Register to secure yours today

JOIN SCI FOR THE 7TH ANNUAL CAPITAL RELIEF TRADES SEMINAR 

SCI are excited to announce the 7th Annual Capital Relief Trades Seminar will take place as a physical event on 13 October 2021. We will return to London with Covid safety measures in place and featuring the same informative and engaging content you’ve grown to expect from SCI, we hope you will join us this October for another must attend event.

Introduction

Last year saw significant regulatory developments in connection with capital relief trades, including the publication of the EBA’s final SRT report and the introduction of an STS synthetics regime. SCI’s Capital Relief Trades Seminar will explore the impact of these developments, as well as the latest trends and activity across the sector.

Exclusive Host

Platinum Sponsor

Silver Sponsors

Bronze Sponsors

Agenda

  • 13 October 2021
    An overview of issuance trends in the capital relief trades market. What are the prospects for risk-sharing deals between supranationals and private investors, given the EIF is scaling back its support for the sector?
    A focus on the EBA’s final SRT report and the development of the STS synthetics regime. What insights does the EBA’s report provide and how are they likely to be incorporated in transactions? How are banks demonstrating commensurate risk transfer in practice? Is the evolution of STS synthetics likely to diverge following Brexit?
    A look at the latest structuring and documentation developments in the CRT market. Will treating excess spread as a first loss tranche hinder issuance? How are banks and investors addressing issues caused by payment holidays?
    Networking Break
    An exploration of issuer perspectives on the CRT market. Are new issuers entering the market? Which barriers to entry remain and what are the potential solutions?
    An examination of investor perspectives on the CRT market. How are investors addressing execution risk? Is secondary trading likely to become a more permanent feature of the CRT market?
    RJ Shea - RenaissanceRe
    Kaelyn Abrell - ArrowMark Partners
    James King - M&G Investments
    An overview of the latest jurisdictions and asset classes to emerge on the CRT scene. What are the prospects for further issuance from Greece, Central and Eastern Europe, and Asia? What impact are ESG considerations having on the market?
    Molly Whitehouse - Newmarket (Moderator)
    Kindly sponsored by